Litcius/Paper detail

Oral Mucosa Could Be an Infectious Target of SARS-CoV-2

Tatsuo Okui, Yuhei Matsuda, Masaaki Karino, Katsumi Hideshima, Takahiro Kanno

2021Healthcare32 citationsDOIOpen Access PDF

Abstract

The World Health Organization reported that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission is caused by respiratory droplets and aerosols from the oral cavity of infected patients. The angiotensin-converting enzyme 2 (ACE2) is considered the host functional protein for SARS-CoV-2 infection. In this article, we first revealed that the positive proportion of ACE2 expression in gingival cells collected from the gingival sulcus was increased to the same level as the tongue. Our data demonstrate that cells in the gingival sulcus may be a new entry point for the SARS-CoV-2 virus via a high expression of ACE2. In addition, we first evaluated the expression of ACE2 in various sites of the oral cavity with noninvasive, convenient liquid-based cytology. The liquid-based cytology evaluation of oral tissue may provide a novel preventive medical avenue against COVID-19.

Topics & Concepts

TongueSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineOral cavityGingival sulcusCoronavirus disease 2019 (COVID-19)Oral mucosaCoronavirusRespiratory systemRespiratory MucosaVirusPathologyVirologyImmunologyDentistryInternal medicineDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesCOVID-19 diagnosis using AIDental Research and COVID-19